RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES
Clinical trials for RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill takes on Hard-to-Treat blood cancers
Disease control Not yet recruitingThis early-stage trial tests a daily pill called APG-3288 in 180 adults with blood cancers like leukemia or lymphoma that have come back or not responded to standard treatments. The main goals are to find the safest dose and check for side effects. Researchers will also look for …
Matched conditions: RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES
Phase: PHASE1 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New shot for tough blood cancers enters first human tests
Disease control Not yet recruitingThis early-stage study tests a new drug called QLS2313 in 124 adults with blood cancers (like lymphoma or leukemia) that returned or didn't respond to standard treatments. The main goal is to check safety and find the right dose, not to cure the disease. Participants receive the …
Matched conditions: RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES
Phase: PHASE1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC